-
Our people
A career shift to further progress for change
-
Our people
Multiple Myeloma Awareness Month
Science on the Sofa features discussions on crucial healthcare topics and the latest expert opinions related to multiple myeloma.
-
Our people
A childhood experience turned to a career
Learn how Kevin's Childhood experience inspired a career in Inclusion and Diversity
-
Our people
Meet Sam, Our US ERG and Outreach Lead
Get to know Sam, Our US ERG and Outreach lead
-
Our people
Meet Colleen, our VP, Head of Inclusion and Diversity
Get to know Colleen, our VP, Head of Inclusion and Diversity
-
How we do business
GSK Celebrating Black History Month
-
Access to healthcare
The Role of Eosinophils in Our Immune System
-
Patients & consumers
Breaking Barriers for Better COPD Care
Survey suggests several gaps in communication and understanding between people with COPD and their care teams.
-
How we do business
Where great consumer brands are born: GSK Richmond R&D Site
Consumer Healthcare’s Richmond (Virginia) R&D Complex is where many iconic GSK brands began – and the next generation is conceived.
-
How we do business
Asthma management: it’s time to get personal
Over 25 million people in the U.S. live with asthma. Could treatable traits help scientists uncover a personalized approach to patient care?
-
Patients & consumers
Don’t settle for persistent asthma symptoms
Recognizing that some symptoms don’t have to be a part of daily life
-
Our people
A summer of products, projects, and priceless experience
-
How we do business
Where ‘consumer obsessed’ meets science: GSK Warren Innovation Lab Suites
-
Innovation
What do Atlantic City and your color TV have in common?
In 1949, Smith Kline & French Laboratories (now GSK) invested in the promise of color television through a partnership with the CBS network.
-
Our people
From GSK Science in the Summer to GSK Scientist
Our own scientist shares the story of how Science in the Summer inspired her and turned her towards a career in STEM
-
How we do business
GSK Navy Yard: Where we do more with less
Nearly 900 employees in the Navy Yard work in open work spaces and in a variety of settings that encourage collaboration and movement.
-
How we do business
GSK named ‘Best Place to Work’ for Disability Inclusion
We’re proud to be named a Best Place to Work for Disability Inclusion this year by Inclusion Inc. on their 2020 Disability Equality Index.
-
Innovation
Who was Percy Julian?
-
How we do business
Celebrating our PRIDE since 1996
-
Innovation
Innovation and R&D leadership during COVID19
Hal joined a panel of top R&D execs to discuss how they've reorganized global teams and tapped new programs as a priority to fight Covid-19.
-
How we do business
Inspiring the next generation of scientists
Science in the Summer gives kids a hands-on way to fall in love with the field’s possibilities. Inspiring tomorrow’s scientists today.
-
Innovation
Immuno-Oncology: Integrating innovation into standard of care practice
In today’s remarkable field of Immuno-Oncology, there is still much yet to discover.
-
How we do business
Building community while celebrating difference through our employee resource groups
Sharing the values of cultural diversity in the workplace
-
How we do business
Celebrating our employees and allies #breakingthesilence to make the workplace more inclusive
-
Patients & consumers
Meet Risa: The right diagnosis and treatment brought a new outlook
-
Innovation
Delivering potentially transformational medicines through R&D innovation in Oncology
Axel Hoos, SVP, Oncology R&D, explains how GSK is driving innovation in Oncology R&D
-
How we do business
Doing our part when disaster hits
We are proud to play our small part - from helping our nonprofit partners across the affected regions in their response efforts, to ensuring patients could continue to access their medicine amid disaster.
-
Innovation
COPD is more than a lung disease
Ruth Tal-Singer works in respiratory research and development. Here she shares her unique perspective on how the future of COPD treatment is changing, and how it's about treating more than just the lung.
-
Innovation
Cancer gets a sting with new discovery
A paper authored by 44 of our scientists was published in the scientific journal Nature, revealing a potential new class of immunotherapy drugs to treat some cancers.
-
Innovation
Vaccines of tomorrow
-
Innovation
You, me and 23andMe...
-
Our people
ATS recognizes curious minds...
Steve Yancey and Dr. Hector Ortega were recognized by the American Thoracic Society with its highest award - The Research Innovation and Translation Achievement Award.
-
Patients & consumers
Meet Jennifer: a science researcher...
As a biomedical researcher at a major medical institution, Jennifer’s happiest days are spent reading, learning, and working on discovering something that will help improve people’s health. While her research includes rare diseases, she never imagined that she’d one day put her skills to use on herself, to unlock the strange mystery going on inside her body.
-
Access to healthcare
Fighting malaria in the lab and on the ground
Despite progress to fight malaria, millions of people continue to suffer every year. We’re helping by researching medicines and vaccines, supporting community prevention and health worker training and strengthening access to medicines.
-
Patients & consumers
A family diagnosis motivates...
As a medical professional, I’m inspired every day to make a difference for COPD patients. As a doctor of pharmacy, I came to GSK motivated by the opportunity to have an impact on patient care.
-
Innovation
How do consumer insights fuel our innovation?
-
Our people
Linking a chapter of GSK history to the fight for freedom
-
Patients & consumers
Controlled asthma, to me, means freedom
Patients give a voice to living with asthma in this video from GSK and the CHEST Foundation.
-
Patients & consumers
If you can’t breathe, you won’t be able to play the tuba
It may seem obvious, but “if you can’t breathe, you’re not going to able to play the tuba very effectively,” said Brendan Bohnhorst, from Grand Rapids, Michigan, USA.
-
Our people
Following the journey of a respiratory medicine
Elaine Jones explains how her passion for helping respiratory patients live every breath motivates her in developing new medicines.
-
Innovation
Lupus: the search for a cure continues
Doctors and their patients face an ongoing battle to manage this chronic and sometimes debilitating and life-threatening condition. See how we’re trying to help.
-
Our people
What I know about asthma… then and now
-
Our people
Crossing off my bucket list, one breath at a time
-
Patients & consumers
Overcoming the challenges of COPD to fulfil a lifelong dream
Joan an 85 year old COPD patient recently achieved her lifelong dream to climb the Great Wall of China. Her daughter Helen tells us Joan’s story.
-
Patients & consumers
Making sense of what consumers want
As a Principal Sensory Scientist in our Consumer Sensory Lab, Hyung describes how we develop products that spark the sensory reaction consumers want.
-
Our people
The science of shopping
Every day millions of consumers use our products. Different countries have different needs and consumers’ shopping habits vary hugely.
-
Our people
Breathing life into an idea for a respiratory medicine
Meet Mark Luttmann, one of our respiratory pioneers. Mark was on the drug discovery team for a key component of several of our COPD medications.
-
Our people
I control my asthma, it doesn’t control me
-
Our people
Thank you for calling GSK...
-
Patients & consumers
Don’t mind me. I’m just making sure I can breathe.
For some, breathing easy sounds simple – it just happens. But for Sarah and for millions of others like her, breathing can be a daily struggle.
-
Our people
Brian Johns goes boldly for people living with HIV
There are over 36 million people living with HIV around the world with an estimated 70% who are not adequately treating the virus.
-
Our people
How curious minds saved a medicine from being left in the lab
See how Steve and his team refined their scientific focus in order to deliver our first biologic respiratory medicine.
-
Access to healthcare
Pricing our medicines to help ensure patient access
We know there is significant frustration in the US regarding the cost of healthcare – including prescription medicines. We take this very seriously, as evidenced by our pricing track record.
-
Access to healthcare
Helping patients in need
-
How we do business
Setting the record straight...
-
How we do business
Hunting for energy savings
You never know what you might find when you hunt for waste.
-
How we do business
Creating bricks and benches out of medical waste
Instead of being incinerated, medical lab waste at our Upper Providence site is being upcycled into bricks and benches.
-
How we do business
Evolving our graduated approach to intellectual property
In developing countries, millions of people have no access to even the most basic healthcare services, including safe and effective medicines.
-
Innovation
On target for a new era of drug discovery?
Almost half a century ago, the world entered an apparent golden era of drug discovery. Driven by a rapidly advancing understanding of biological processes in the body and medicinal chemistry, a generation of game-changing new medicines emerged.
-
How we do business
Buyer beware: importing drugs comes with big risks
-
How we do business
How doctors and insurers get information about medicines
-
Patients & consumers
Living with COPD Every Day: Sean’s Story
Pinch your nose and try breathing through a straw? Not so easy, right?
-
Innovation
Getting on target in autoimmune diseases
Our immune system is a complex network of cells in our bodies that work together to protect us from harmful germs.But what happens when these cells malfunction?
-
Patients & consumers
Inspiring Students through STEM Education Programs
In the next five years, the US will add eight million jobs in STEM fields. Yet more than 20% of all students, and half of all minority students, drop out of school before graduation.
-
Innovation
Scientists or detectives? Seeking new clues in COPD
It is now widely accepted that COPD is not a uniform disease, but effects of the disease can impact people differently.
-
How we do business
Helping to change the world
-
Access to healthcare
Global mission, local impact
-
Access to healthcare
In Africa, markets matter for a healthy society
When it comes to improving access to healthcare in Africa, markets matter. From pharmaceutical companies to small clinics, an interconnected private market complements public sector services to help patients receive the healthcare they need, when and where they need it.
-
Innovation
Take a deep breath – your lung microbiome will appreciate it
Scientists are discovering just how important microbes are in maintaining our respiratory health and immunity
-
Innovation
Cell and gene therapy: a new era of medicine
If we can pinpoint a faulty gene and correct it, could we potentially find a way to cure genetic diseases?